|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006104,
umls-concept:C0028582,
umls-concept:C0036043,
umls-concept:C0040044,
umls-concept:C0040399,
umls-concept:C0121638,
umls-concept:C0203860,
umls-concept:C0205178,
umls-concept:C0233929,
umls-concept:C0520997,
umls-concept:C0556656,
umls-concept:C0680022,
umls-concept:C0948008,
umls-concept:C1551807,
umls-concept:C2603343,
umls-concept:C2827395
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
1997-10-9
|
|
pubmed:abstractText |
To reliably identify patients at risk for symptomatic hemorrhagic transformation (SHT), future trials of thrombolysis for acute ischemic stroke might use a vascular imaging protocol applicable to a multicenter setting. The goal of this commentary is to address the safety of intravenous thrombolysis with the recombinant tissue plasminogen activator (rTPA) and potential solutions offered by single-photon emission CT (SPECT) as a noninvasive brain perfusion imaging modality.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0039-2499
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1830-4
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9303032-Acute Disease,
pubmed-meshheading:9303032-Brain,
pubmed-meshheading:9303032-Brain Ischemia,
pubmed-meshheading:9303032-Cerebrovascular Disorders,
pubmed-meshheading:9303032-Humans,
pubmed-meshheading:9303032-Nuclear Medicine,
pubmed-meshheading:9303032-Organotechnetium Compounds,
pubmed-meshheading:9303032-Oximes,
pubmed-meshheading:9303032-Safety,
pubmed-meshheading:9303032-Societies, Medical,
pubmed-meshheading:9303032-Technetium Tc 99m Exametazime,
pubmed-meshheading:9303032-Thrombolytic Therapy,
pubmed-meshheading:9303032-Tomography, Emission-Computed, Single-Photon
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Brain single-photon emission CT with HMPAO and safety of thrombolytic therapy in acute ischemic stroke. Proceedings of the meeting of the SPECT Safe Thrombolysis Study Collaborators and the members of the Brain Imaging Council of the Society of Nuclear Medicine.
|
|
pubmed:affiliation |
University of Texas, Houston 77030, USA. avalexandrov@worldnet.att.net
|
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|
